Tumor/Lymph Node Dual‐Targeting Ultrasonic Nanoconverter Orchestrates Spatiotemporal ROS Regulation for Dual‐Zone Programmed Sono‐STING Immunotherapy
Researchers have engineered a dual‑targeting ultrasonic nanoconverter (OPD@PSF) that co‑delivers the sonosensitizer protoporphyrin IX and the STING agonist Vadimezan to breast tumors and their draining lymph nodes. High‑power ultrasound at the tumor site generates abundant reactive oxygen species, inducing immunogenic cell death, while low‑power ultrasound in the lymph nodes produces moderate ROS that activates immune cells. The combined ROS‑driven sonodynamic therapy and STING activation suppresses primary tumor growth and eliminates metastasis in pre‑clinical models. The platform demonstrates a scalable nanotechnological approach for spatiotemporal immune modulation.
Addressing Racial and Ethnic Health Disparities: Insights From the 2026 Commonwealth Fund Report
The Commonwealth Fund’s 2026 State Health Disparities Report shows racial and ethnic gaps in access, quality and outcomes exist in every U.S. state. The data, reflecting system performance through 2024, warn that recent policy shifts—such as Medicaid funding cuts and...
Skyn Launches ‘World’s Thinnest’ Non-Latex Condoms
LifeStyles Healthcare Australia introduced Skyn Supreme Feel, a polyisoprene condom touted as the world’s thinnest non‑latex option. The product uses a patented synthetic material that is latex‑free, soft, and stretchy, and it has undergone clinical testing against top latex ultra‑thin condoms....
Surviving VA Slashes: Home Care Providers Report Rate Cut Impacts
In November, the U.S. Department of Veterans Affairs slashed reimbursement rates for home health aide and homemaker services, cutting Texas rates by 43% and New Mexico rates by 19%. The reductions have forced providers like Live Well Home Care to stretch...
Which Colorectal Cancer Screening Method Is Right for You?
Colorectal cancer screening saves lives, with colonoscopy remaining the gold‑standard due to its 70% detection rate and ability to remove polyps during the exam. Alternative methods include virtual colonoscopy, flexible sigmoidoscopy, stool‑based FIT/DNA tests, and the newly FDA‑approved Shield™ blood...
Why We Need to Ease the Path to Post-Prison Health Care
Every year roughly 600,000 Americans leave prison, and the majority qualify for Medicaid, a critical lifeline for chronic health needs and family stability. Starting Jan. 1 2027, Medicaid will impose nationwide work requirements, giving newly released individuals only 90 days to log...
DOJ Reclassifies Medical Marijuana to Schedule III: Key Implications for Florida and National Cannabis Operators
The U.S. Department of Justice has reclassified state‑licensed medical marijuana from Schedule I to Schedule III, the most significant federal cannabis reform in five decades. The change applies only to FDA‑approved cannabis products and state‑run medical programs, leaving adult‑use and illicit markets...
The Antitrust Scrutiny Continues: FTC Launches New Healthcare Task Force
On April 28, 2026 the Federal Trade Commission announced a new Healthcare Task Force designed to unify its Competition, Consumer Protection, Economics, Planning and Technology bureaus. The task force will focus on antitrust risks in health‑care consolidation, pricing practices and...
What Are Peptides And Why Is Everyone Talking About Them?
Peptide therapies, short chains of amino acids that act like hormones, have surged in popularity as wellness supplements promising vitality and longevity. The most clinically vetted peptide, GLP‑1, is now used by roughly 10 million Americans for obesity and appetite control,...
The Secretary Of Health & Human Services Doesn’t Believe In The Foundation Of Modern Medicine
Robert F. Kennedy Jr. publicly denied the germ theory of disease during a Senate hearing on the measles outbreak, prompting sharp rebuke from Senators Bernie Sanders and Bill Cassidy. Kennedy cited outdated studies to argue that sanitation, not vaccines, reduced...
Swept-Source Optical Coherence Tomography Angiography May Predict Diabetic Nephropathy
A Harvard‑based study published in the July issue of the American Journal of Ophthalmology shows that swept‑source optical coherence tomography angiography (OCTA) can serve as a non‑invasive biomarker for diabetic nephropathy. Researchers analyzed 375 eyes from 234 diabetic patients and...
A Novel Gene-Therapy Approach to ‘Functionally Cure’ HIV Succeeds in some Monkeys
Researchers used an adeno‑associated virus to deliver a gene that produces a CCR5‑blocking antibody in rhesus macaques. Six of the 19 treated monkeys maintained undetectable SHIV levels for over a year after a single low‑dose injection, showing a functional cure....
Independent, Academic Cancer Trials Are Vital to Improve Patient Outcomes Worldwide
A Lancet Oncology Commission has been launched to evaluate the role of independent, academic cancer trials worldwide. The initiative stems from a coalition of 35 investigators and patient advocates spanning six continents, coordinated by the European Organisation for Research and...
Patients Treated for Common Cancers in Community Settings Live Longer, COA Study Finds
A COA‑commissioned study using Flatiron Health and SEER data shows patients with metastatic breast cancer and metastatic NSCLC treated in community oncology practices have longer overall survival than national benchmarks. Median survival for metastatic breast cancer was 48 months versus...
Biogen Inc (BIIB) Q1 2026 Earnings Call Transcript
Biogen reported $2.8 billion revenue for Q1 2026, a 7% increase driven by four new launch products and resilient U.S. multiple‑sclerosis sales. Non‑GAAP diluted EPS rose 4% to $5.25, and the company lifted its 2025 EPS guidance to $15.50‑$16 while keeping revenue...
Acadia Healthcare Company Inc (ACHC) Q1 2026 Earnings Call Transcript
Acadia Healthcare reported Q3 2025 revenue of $851.6 million, a 4.4% year‑over‑year increase, but adjusted EBITDA slipped to $173 million, $5 million below internal forecasts. The company lowered its full‑year outlook, trimming revenue to $3.28‑$3.30 billion and adjusted EBITDA to $650‑$660 million....
Improving Access to Essential Medicines via Decision-Aware Machine Learning
A new wave of decision‑aware machine‑learning models is being applied to pharmaceutical supply chains in low‑income regions, blending demand forecasts with inventory and distribution constraints. Early pilots in Zambia and Rwanda report up to a 30% reduction in stock‑outs and...
Amarin Corporation PLC (AMRN) Q1 2026 Earnings Call Transcript
Amarin Corporation reported first‑quarter 2024 net revenue of $56.5 million, down from $86 million a year earlier, as U.S. sales fell amid generic competition. The company secured an extended European patent runway for VASCEPA through 2039, reinforcing its market position. European commercial...
Agios Pharmaceuticals Inc (AGIO) Q1 2026 Earnings Call Transcript
Agios Pharmaceuticals reported a 45% year‑over‑year jump in PYRUKYND net revenue to $12.5 million, driven by stronger PKD sales, an extra ordering week, and higher specialty‑pharmacy processing. The company ends the quarter with roughly $1.3 billion in cash, supporting both commercial rollout...
GE Healthcare Technologies Inc (GEHC) Q1 2026 Earnings Call Transcript
GE Healthcare Technologies reported Q1 2026 revenue of $5.7 billion, up 4.8% organically, and posted a record $21.8 billion backlog with a book‑to‑bill ratio above 1. Adjusted EBIT margin fell to 16.7% due to roughly $100 million in tariff expenses and an unfavorable...
Safety and Efficacy of Intratumoural Anti-CTLA4 with Intravenous Anti-PD1
The phase 1b NIVIPIT trial compared intratumoural (IT) ipilimumab at 0.3 mg kg⁻¹ plus intravenous nivolumab with the standard intravenous (IV) ipilimumab‑nivolumab regimen in untreated advanced melanoma. The IT arm achieved a markedly lower rate of grade 3‑4 treatment‑related adverse events (24 % vs 67 %...
Ionis Pharmaceuticals Inc (IONS) Q1 2026 Earnings Call Transcript
Ionis Pharmaceuticals reported record 2025 revenue of $944 million, a 34% year‑over‑year increase driven by strong sales of TRYNGOLZA, the launch of DAWNZERA, and robust R&D collaboration fees. Phase III data for olezarsen demonstrated up to a 72% reduction in triglycerides and...
Conmed Corp (CNMD) Q1 2026 Earnings Call Transcript
Conmed Corp reported Q1 2026 results with total sales of $373.2 million, a 7.9% year‑over‑year increase, and full‑year revenue of $1.375 billion, up 5.2%. Orthopedic sales led growth, rising 12.1% in the quarter and 5.5% for the year, while international sales surged...
Urban Edge Properties (UE) Q1 2026 Earnings Call Transcript
Urban Edge Properties reported Q1 2026 net revenue of $12.5 million, a 45% year‑over‑year increase driven by stronger PKD sales, an extra ordering week, and expanded specialty pharmacy distribution. Patient enrollment rose to 248 completed forms with 142 patients now on...
Regeneron Pharmaceuticals Inc (REGN) Q1 2026 Earnings Call Transcript
Regeneron reported Q1 2025 revenue of $3 billion, with Dupixent and Libtayo delivering double‑digit growth while U.S. EYLEA sales fell 39% to $736 million amid co‑pay assistance gaps and rising Avastin use. Gross margin guidance was revised to 86‑87% after larger‑than‑expected inventory...
Anika Therapeutics Inc (ANIK) Q1 2026 Earnings Call Transcript
Anika Therapeutics posted total revenue of $28.2 million for the quarter, an 8% decline driven by manufacturing yield issues and a $900,000 shortfall in international osteoarthritis‑pain sales. Gross margin fell to 51%—down 16 percentage points—after a one‑time $3 million non‑cash charge, though...
AbbVie Inc (ABBV) Q1 2026 Earnings Call Transcript
AbbVie reported Q1 2024 revenue of $12.3 billion and adjusted earnings per share of $2.31, both topping internal forecasts. The company highlighted more than 15% growth from its post‑Humira portfolio, driven by double‑digit gains in Skyrizi, Rinvoq, Venclexta and other assets....
CDC Confirms Rare Imported Case of Measles From Japan in 7 Years
The Taiwan Centers for Disease Control confirmed a measles case in a 30‑year‑old Taiwanese man who returned from Japan, marking the first imported case from that country in seven years. Japan has reported a surge to 299 measles cases this...
Cancer Is Increasing in Young People and We Still Don't Know Why
Recent research shows colorectal cancer among young adults is climbing sharply, with a 50% increase since the 1990s in several high‑income nations. A UK study identified 11 cancer types rising in people aged 20‑49, attributing only a small share of...
UConn Health Signs Letter of Intent for 2 Hospitals
UConn Health announced a letter of intent to bring Day Kimball Hospital and Bristol Health into its network, extending the academic medical center’s reach in Connecticut. The move follows UConn Health’s March acquisition of Waterbury Hospital from the bankrupt Prospect...
How Tech Can Bridge Gaps in Rural Healthcare Data Struggles
The Office of the National Coordinator for Health IT is pushing technology to cut costs and improve care in rural America. A new ONC mandate requires electronic health records to show prescription benefit information, giving patients price transparency at the...
UTHealth Houston Names Business Affairs, Strategy Chief
UTHealth Houston announced the appointment of Michael Patriarca as executive vice president and chief business affairs and strategy officer. The newly created role is designed to steer long‑range strategic planning while overseeing finance, operations, IT, data analytics, and infrastructure. Patriarca...
Air Pollution Exposure in the Womb Linked to Worse Language and Motor Development
A King's College London study of 498 Greater London infants links first‑trimester air‑pollution exposure to lower language scores at 18 months and, for pre‑term babies, to markedly poorer motor development. Children whose mothers lived in high‑pollution areas scored 5‑7 points lower...
Site-Neutral Payment Debate Intensifies in Hospital Affordability Hearing
During a House Ways and Means hearing, hospital CEOs and lawmakers debated site‑neutral payment as a lever to curb soaring hospital costs, which have risen roughly 170% since 2005. Republicans touted proposals that could save $160 billion in taxes and $672 billion...
MultiCare to Open $479M Mary Bridge Children’s Hospital May 16
MultiCare is set to open the new Mary Bridge Children’s Hospital in Tacoma on May 16, a $479 million, six‑story facility that replaces the original 1955 campus. The hospital features eight operating rooms, 29 emergency‑department exam rooms, dedicated play spaces and...
CMS Veteran Blum Warns a Version of the Nursing Home Staffing Rule Could Return After November
Former CMS chief operating officer Jonathan Blum warned that a version of the controversial nursing‑home staffing mandate could be revived after the November midterms if Democrats regain control of the House. He told the LTC 100 Leadership conference that policymakers must...
‘Low-Hanging Fruit’: Nationwide Survey of Nursing Home Staff Shows Easy Fixes for Retention Amid Managed Care, PDPM Burdens
A nationwide AAPACN/LTC 100 survey of 489 skilled‑nursing‑facility nurses shows 65% overall job happiness but highlights documentation duplication across Medicaid, PDPM and managed‑care as a major stressor. Retention is driven by purpose, resident connections and a positive team culture, especially relationships...
AI Model Detects Normally 'Invisible' Tissue Changes of Pancreatic Cancer at Stage 0
Researchers unveiled REDMOD, an AI radiomics framework that identifies stage 0 pancreatic ductal adenocarcinoma on routine CT scans. In a multi‑institutional study of 219 cancer cases and 1,243 controls, REDMOD flagged disease an average of 475 days before clinical diagnosis, achieving 73%...
Bowel and Ovarian Cancer Cases Rising Among Younger Adults in England, Research Reveals
A BMJ Oncology study of England’s cancer registry (2001‑2019) shows bowel and ovarian cancers are the only two types rising among adults under 50, while rates for older adults remain stable or decline. The analysis links excess weight to ten...
AI, Face Photos May Predict Cancer Survival: Mass General Brigham Study
Mass General Brigham researchers validated FaceAge, an AI tool that estimates biological age from facial photographs, as a survival predictor for cancer patients. The study examined two routine photos per patient for 2,279 individuals, finding that changes in the Face...
Tonsillectomy Doesn’t Lead To Illness, But Tonsillitis Just Might
A recent UK Biobank analysis of nearly 500,000 people shows that higher rates of inflammatory disorders such as IBS among those who had tonsillectomy are actually tied to earlier tonsil infections, not the surgery itself. This finding overturns a 2018...
Beth Israel Lahey Health Rolls Out AI Scribe Systemwide
Beth Israel Lahey Health, a 14‑hospital system in Massachusetts, has selected Heidi as its systemwide AI scribe vendor. After a six‑month pilot involving 1,000 physicians, the health system began rolling out the technology to all providers. Clinicians reported higher note...
The BioPharm Brief: Expanding Access and Redefining Cancer Treatment
Henlius and Organon received European Commission approval for a pertuzumab biosimilar, expanding HER2‑targeted therapy access across the EU. Pfizer announced Phase 3 data showing its bispecific antibody Elrexfio improves progression‑free survival in relapsed or refractory multiple myeloma. Genexine disclosed pre‑clinical activity...
IV Fluids Recalled over Possible Contamination—Patients Face Risk of Vascular Complications
B. Braun Medical is recalling two lots of its 1‑liter Lactated Ringer’s IV electrolyte solution (lots J4P756 and J4S843) after detecting particulate matter that could trigger pulmonary emboli, vessel occlusions, or phlebitis. The affected bags were distributed across the United States...
Judy Faulkner: Profitability Is a ‘Side Effect,’ Not the Goal
Epic Systems, led by founder‑CEO Judy Faulkner, continues to prioritize patient‑centric software over profit maximization, even as its revenue climbs to about $6.7 billion in 2025. Faulkner describes profitability as a "side effect" of delivering value, a stance enabled by the...
Wastewater Surveillance Supports COVID-19 Screening in Hospitals
A retrospective study at University Hospital Basel linked SARS‑CoV‑2 concentrations in municipal wastewater to COVID‑19 positivity among asymptomatic patients screened on admission. The analysis of 75,667 PCR tests showed a 1.2% positivity rate, with stronger correlations during periods of high...
Higher Lp(a) Threshold More Closely Linked to Major ASCVD Events
A pooled analysis of three large randomized trials found that lipoprotein(a) levels of ≥ 175 nmol/L independently predict all‑cause mortality, cardiovascular death and stroke over seven years, with risk comparable to current smoking. The association was strongest in secondary‑prevention patients and was not...
Ultralow-Temperature Cryoablation Shows Promise for VT
The FULCRUM‑VT IDE trial evaluated Adagio Medical’s vCLAS ultralow‑temperature cryoablation system in 209 patients with monomorphic ventricular tachycardia. At six months, 59% of participants remained free of recurrent VT, ICD interventions, and antiarrhythmic escalation, while acute success reached 98% non‑inducibility....
Allina Health Cybersecurity Chief Joins Baylor Scott & White
William Scandrett, former vice president and chief information security officer at Allina Health, has been appointed vice president of information security and chief information security officer at Baylor Scott & White Health. Scandrett announced the move on LinkedIn on April 28, highlighting his...
NPHI Execs: Quality Is Hospices’ Differentiator
At its annual Chicago summit, NPHI CEO Tom Koutsoumpas and President Carole Fisher argued that quality—beyond regulatory metrics—is the key differentiator for nonprofit hospices. NPHI’s Innovation Lab has launched quality dashboards that capture “Measures that Matter,” such as live discharges,...